tiprankstipranks
Abeona Therapeutics (ABEO)
NASDAQ:ABEO
US Market
ABEO
Abeona Therapeutics
RESEARCH TOOLSreports

Abeona Therapeutics (ABEO) Stock News & Sentiment

1,541 Followers
Abeona Therapeutics Adds Keith Goldan to Board, Audit Chair
Premium
Company Announcements
Abeona Therapeutics Adds Keith Goldan to Board, Audit Chair
2d ago
8K
ABEO
Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules
Premium
Company Announcements
Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules
20d ago
8K
ABEO
Early-Stage ZEVASKYN Momentum and Attractive Economics Underscore Abeona’s Undervalued Growth Potential and $20 Buy Rating
Premium
Ratings
Early-Stage ZEVASKYN Momentum and Attractive Economics Underscore Abeona’s Undervalued Growth Potential and $20 Buy Rating
21d ago
ABEO
Abeona Therapeutics Balances Big Windfall With Slow Ramp
Premium
Company Announcements
Abeona Therapeutics Balances Big Windfall With Slow Ramp
22d ago
ABEO
Options Volatility and Implied Earnings Moves Today, March 17, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 17, 2026
23d ago
ASO
TME
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
24d ago
M
MU
ABEO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ABEO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
25d ago
ABEO
More ABEO News >

ABEO News on the Web

Abeona Therapeutics Adds Keith Goldan to Board, Audit Chair
TipRanks News
Neutral
Insider Sell: Vishwas Seshadri Sells 29,985 Shares of Abeona Therapeutics Inc (ABEO)
GuruFocus News
Neutral
Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules
TipRanks News
Neutral
Early-Stage ZEVASKYN Momentum and Attractive Economics Underscore Abeona’s Undervalued Growth Potential and $20 Buy Rating
TipRanks News
Bullish
Abeona Therapeutics (ABEO) Receives a Buy from Stifel Nicolaus
TipRanks News
Bearish
Abeona Therapeutics (ABEO) Receives a Buy from Oppenheimer
TipRanks News
Neutral
Abeona Therapeutics Balances Big Windfall With Slow Ramp
TipRanks News
Neutral
Abeona Therapeutics price target lowered to $20 from $27.50 at Alliance Global
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
ABEO
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.75 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ABEO’s Media Buzz Sentiment?
1 articles about ABEO were published this week. In an average week, 3.75 articles are published.
    What is ABEO’s weekly average amount of articles?
    In an average week, 3.75 articles about ABEO are published.
      What is ABEO’s News Sentiment?
      50% of articles about ABEO were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        AORTArtivion
        HUMHumana
        ORGOOrganogenesis Holdings
        UNHUnitedHealth Group Incorporated Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S
        Showing the stocks with the most bullish news sentiment over the past week